杆菌感染的诊断和治疗:过去,现在和未来
1Digestive Disease Center, Soonchunhyang University Hospital, Seoul, Korea.
Future microbiology
|October 6, 2025
概括
杆菌 (H. pylori) 感染会增加胃癌的风险. 抗生素耐药性的增加需要新的H. pylori根除策略,分子诊断和微生物组测序提供有希望的解决方案.
科学领域:
- 胃肠病学 胃肠病学
- 传染性疾病 传染性疾病
- 在瘤学瘤学.
背景情况:
- 杆菌感染影响了全球一半以上的人口,导致癌前胃病,如缩性胃炎和肠道转化等.
- 这些疾病可能会发展为胃病和胃癌,在2020年全球估计造成76.9万例死亡.
- 国际指导方针建议根除H. pylori以减少胃癌死亡率,但抗生素耐药性增加挑战了标准治疗方法.
研究的目的:
- 审查关于H. pylori管理的最新证据,重点关注诊断和治疗策略.
- 在抗生素耐药性增加的背景下,指导开发有效的测试和根除方案.
- 为临床医生提供关于H. pylori诊断,治疗史,经验方案,分子测试和胃微生物组分析的最新信息.
主要方法:
- 关于H. pylori诊断和治疗近期进展的综合文献综述.
- 对分子技术和基因组测序应用在H. pylori管理中的分析.
- 检查历史治疗指导方针和实证根除方案的演变.
主要成果:
- 在过去的十年中,分子技术和基因组测序显著推进了H. pylori的诊断和治疗.
- 在H. pylori的抗生素耐药性损害了标准根除效果,强调了需要替代策略.
- 该综述涵盖了优化诊断,治疗史,更新的实证方案,针对量身定制的根除分子诊断和下一代胃微生物组测序.
结论:
- 由于抗生素耐药性增加,有效的H. pylori管理需要更新策略.
- 分子诊断和微生物组分析是个性化H. pylori根除的关键进展.
- 本综述为临床医生提供了当前证据,以优化H. pylori的测试和治疗,旨在减少胃癌负担.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
739
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
1.1K
相关概念视频
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.1K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.1K
01:26Peptic Ulcer Disease IV: Management
430
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
430
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
536
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
536
01:23Gastritis III: Clinical Manifestations and Management
1.2K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.2K
01:30Peptic Ulcer Disease I: Introduction
742
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
742
01:13Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
845
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
845